InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.85
(
1.06%
)
Bitcoin
69,624.18
(
1.62%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: None

Monday, 08/08/2011 8:05:00 PM

Monday, August 08, 2011 8:05:00 PM

Post# of 92948
Conference Call,



* Rabin is permanent CEO(real shocker eh louisa?)

* 2 other clinical trial sites coming online

* BOD Erkki Ruoslahti out, 2 new BOD's to be added.

* Lanza signed extended employment contract, employment contracts will be filed soon

* Comments on trials mum as they should be

* No joint venture in EU if CTA approved, will do as we are doing here.

* Paid $800K for Noth America/Canada hemangioblast rights

* Taking on the 10 scientists from SCRMI and research set to cost around $2MM per year

* RS questions were addressed by saying if they did one it will be timed with an event. Rabin no doubt would like the support from institutions and mutual funds frim a big board.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up